Pekka Kurki - Publications, H-index & Citations

Pekka Kurki

Johns Hopkins Medicine

40H指数

151论文数

5.4K被引数

收录论文 14

发表时间

Copies of Biological Medicines: Similar But Not the Same?

BIODRUGS

IF6.9

2023-01-30

OAAI

Kurki, Pekka

Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience

BIODRUGS

IF6.9

2022-05-21

OAAI

Kurki, Pekka; Kang, Hye-Na; Ekman, Niklas; Knezevic, Ivana; Weise, Martina; Wolff-Holz, Elena

Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective

DRUGS

IF14.4

2021-10-01

OAAI

Kurki, Pekka; Barry, Sean; Bourges, Ingrid; Tsantili, Panagiota; Wolff-Holz, Elena

Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review

BIODRUGS

IF6.9

2021-08-16

OAAI

Tolonen, Hanna M.; Falck, Jenni; Kurki, Pekka; Ruokoniemi, Paivi; Hameen-Anttila, Katri; Shermock, Kenneth M.; Airaksinen, Marja

Interchangeability of Biosimilars: A European Perspective

BIODRUGS

IF6.9

2017-01-24

148

PREAI

Kurki, Pekka; van Aerts, Leon; Wolff-Holz, Elena; Giezen, Thijs; Skibeli, Venke; Weise, Martina

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2015-08-18

PREAI

Kurki, Pekka; Ekman, Niklas

ECCO position challenged by European drug regulators

JOURNAL OF CROHNS & COLITIS

IF8.7

2014-03-01

PREAI

Kurki, Pekka; Bielsky, Marie-Christine

A European perspective on immunogenicity evaluation

NATURE BIOTECHNOLOGY

IF41.7

2009-06-01

PREAI

Schneider, Christian K.; Papaluca, Marisa; Kurki, Pekka

Long term efficacy and safety of cyclosporin versus parenteral old in early rheumatoid arthritis:: a three year study of radiographic progression, renal function, and arterial hypertension

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2002-06-01

OAAI

Kvien, TK; Zeidler, HK; Hannonen, P; Wollheim, FA; Forre, O; Hafström, I; Kaltwasser, JP; Leirisalo-Repo, M; Manger, B; Laasonen, L; Prestele, H; Kurki, P

Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2001-05-01

OAAI

Albers, JMC; Paimela, L; Kurki, P; Eberhardt, KB; Emery, P; van't Hof, MA; Schreuder, FHJM; Leirisalo-Repo, M; van Riel, PLCM

Serum immunoglobulins and the risk of rheumatoid arthritis

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

1997-06-01

OAAI

Aho, K; Heliovaara, M; Knekt, P; Reunanen, A; Aromaa, A; Leino, A; Kurki, P; Heikkila, R; Palosuo, T

ANTIKERATIN ANTIBODIES - DIAGNOSTIC AND PROGNOSTIC MARKERS FOR EARLY RHEUMATOID-ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

1992-06-01

OAAI

PAIMELA, L; GRIPENBERG, M; KURKI, P; LEIRISALOREPO, M

AUTOANTIBODIES IN INFECTIOUS-MONONUCLEOSIS HAVE SPECIFICITY FOR THE GLYCINE-ALANINE REPEATING REGION OF THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN

JOURNAL OF EXPERIMENTAL MEDICINE

IF10.6

1987-04-01

OAAI

RHODES, G; RUMPOLD, H; KURKI, P; PATRICK, KM; CARSON, DA; VAUGHAN, JH

GLIAL FIBRILLARY ACIDIC PROTEIN AND INTERMEDIATE FILAMENTS IN HUMAN GLIOMA-CELLS

ACTA NEUROPATHOLOGICA

IF9.3

1979-01-01

PREAI

PAETAU, A; VIRTANEN, I; STENMAN, S; KURKI, P; LINDER, E; VAHERI, A; WESTERMARK, B; DAHL, D; HALTIA, M

研究方向